• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-乙酰半胱氨酸在帕金森病中的应用现状与未来展望:一项文献网络分析

Current trends and future prospects of N-acetylcysteine utilizations in Parkinson's disease: A literature network analysis.

作者信息

Muthmainah Muthmainah, Wiyono Nanang, Syah Faris K, Purnianto Adityas, Yudhani Ratih D, Wasita Brian

机构信息

Department of Anatomy, Faculty of Medicine, Universitas Sebelas Maret, Indonesia.

Doctoral Program in Medical Science, Faculty of Medicine, Universitas Sebelas Maret, Indonesia.

出版信息

J Taibah Univ Med Sci. 2025 May 29;20(3):298-306. doi: 10.1016/j.jtumed.2025.05.004. eCollection 2025 Jun.

DOI:10.1016/j.jtumed.2025.05.004
PMID:40510771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12162018/
Abstract

Parkinson's disease (PD) is a prevalent neurodegenerative disorder without a definitive cure. Oxidative stress is significantly implicated in its pathogenesis, prompting interest in N-acetylcysteine (NAC), a strong antioxidant and cysteine precursor, as a potential therapeutic agent. We conducted a bibliometric analysis of 421 Scopus articles to assess current trend and future potential of research on the use of NAC in Parkinson's disease. The number of publications related to this topic reached the peaked in 2010 and gradually decreased afterward. We identified 4 main clusters of research theme related to the potential mechanism of NAC effects on Parkinson's disease progression. These include research focusing on NAC effects on oxidative stress, dysfunction of the mitochondria, aberrant protein accumulation and clearance and inflammation. Investigating NAC effect for Parkinson's disease in human is a potential research area.

摘要

帕金森病(PD)是一种常见的神经退行性疾病,尚无确切的治愈方法。氧化应激在其发病机制中具有重要作用,这引发了人们对N-乙酰半胱氨酸(NAC)的兴趣,NAC是一种强大的抗氧化剂和半胱氨酸前体,有望成为一种潜在的治疗药物。我们对421篇Scopus文章进行了文献计量分析,以评估使用NAC治疗帕金森病的研究现状和未来潜力。与该主题相关的出版物数量在2010年达到峰值,之后逐渐减少。我们确定了与NAC对帕金森病进展影响的潜在机制相关的4个主要研究主题集群。这些包括聚焦于NAC对氧化应激、线粒体功能障碍、异常蛋白质积累和清除以及炎症影响的研究。研究NAC对人类帕金森病的影响是一个潜在的研究领域。

相似文献

1
Current trends and future prospects of N-acetylcysteine utilizations in Parkinson's disease: A literature network analysis.N-乙酰半胱氨酸在帕金森病中的应用现状与未来展望:一项文献网络分析
J Taibah Univ Med Sci. 2025 May 29;20(3):298-306. doi: 10.1016/j.jtumed.2025.05.004. eCollection 2025 Jun.
2
Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.帕金森病中重复剂量口服N-乙酰半胱氨酸:药代动力学及其对脑内谷胱甘肽和氧化应激的影响
J Clin Pharmacol. 2018 Feb;58(2):158-167. doi: 10.1002/jcph.1008. Epub 2017 Sep 22.
3
N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.N-乙酰半胱氨酸预防大鼠鱼藤酮诱导的帕金森病:对帕金蛋白和动力相关蛋白1相互作用的研究
Brain Res Bull. 2015 Apr;113:34-40. doi: 10.1016/j.brainresbull.2015.02.007. Epub 2015 Feb 28.
4
N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson's Disease.N-乙酰半胱氨酸纳米载体在帕金森病细胞模型中对抗氧化应激
Antioxidants (Basel). 2020 Jul 9;9(7):600. doi: 10.3390/antiox9070600.
5
Bibliometric analysis of microRNAs and Parkinson's disease from 2014 to 2023.2014年至2023年关于微小RNA与帕金森病的文献计量分析
Front Neurol. 2024 Sep 25;15:1466186. doi: 10.3389/fneur.2024.1466186. eCollection 2024.
6
Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases.乙酰半胱氨酸在神经退行性疾病中的作用概述。
Molecules. 2018 Dec 13;23(12):3305. doi: 10.3390/molecules23123305.
7
Mapping the research of nursing in Parkinson's disease: a bibliometric and quantitative analysis.帕金森病护理研究图谱:文献计量与定量分析
Front Neurol. 2024 Sep 25;15:1412158. doi: 10.3389/fneur.2024.1412158. eCollection 2024.
8
Target oxidative stress-induced disulfidptosis: novel therapeutic avenues in Parkinson's disease.靶向氧化应激诱导的二硫键化细胞死亡:帕金森病的新型治疗途径
Mol Brain. 2025 Apr 4;18(1):29. doi: 10.1186/s13041-025-01200-2.
9
Trends and hotspots on the relationship between gut microbiota and Parkinson's Disease: a bibliometric analysis.肠道微生物群与帕金森病关系的研究趋势和热点:文献计量分析。
Front Cell Infect Microbiol. 2024 Sep 30;14:1421270. doi: 10.3389/fcimb.2024.1421270. eCollection 2024.
10
High-Mobility Group Box 1 (HMGB1) Protein in Parkinson's Disease Research: A 10-Year Bibliometric Analysis.帕金森病研究中的高迁移率族蛋白盒1(HMGB1):一项十年文献计量分析
J Integr Neurosci. 2023 Jul 4;22(4):87. doi: 10.31083/j.jin2204087.

本文引用的文献

1
Exploring the utility of N-acetylcysteine for loss of control eating: protocol of an open-label single-arm pilot study.探索N-乙酰半胱氨酸对失控性进食的效用:一项开放标签单臂试点研究的方案
Pilot Feasibility Stud. 2025 Feb 19;11(1):19. doi: 10.1186/s40814-025-01598-5.
2
-acetylcysteine increases dopamine release and prevents the deleterious effects of 6-OHDA on the expression of VMAT2, α-synuclein, and tyrosine hydroxylase.乙酰半胱氨酸增加多巴胺的释放,并防止 6-OHDA 对 VMAT2、α-突触核蛋白和酪氨酸羟化酶表达的有害影响。
Neurol Res. 2024 May;46(5):406-415. doi: 10.1080/01616412.2024.2325312. Epub 2024 Mar 18.
3
N-acetylcysteine modulates rotenone-induced mitochondrial Complex I dysfunction in THP-1 cells.
N-乙酰半胱氨酸调节罗替戈汀诱导的 THP-1 细胞中线粒体复合物 I 功能障碍。
Mitochondrion. 2023 Sep;72:1-10. doi: 10.1016/j.mito.2023.07.001. Epub 2023 Jul 5.
4
Post-inflammatory administration of -acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease.炎症后给予N-乙酰半胱氨酸可减轻帕金森病细胞模型中的炎症并改变受体水平。
FASEB Bioadv. 2023 May 16;5(7):263-276. doi: 10.1096/fba.2022-00145. eCollection 2023 Jul.
5
Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19.COVID-19 危重症患者静脉注射 N-乙酰半胱氨酸的反应。
Nutrients. 2023 May 8;15(9):2235. doi: 10.3390/nu15092235.
6
N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson's Disease Rat Model.在纹状体6-羟基多巴胺帕金森病大鼠模型中,N-乙酰半胱氨酸治疗可能通过调节多巴胺能传递来补偿运动障碍。
Antioxidants (Basel). 2023 Jun 11;12(6):1257. doi: 10.3390/antiox12061257.
7
Research on biochar a comprehensive scientometric approach.生物炭研究:一种综合的科学计量学方法。
RSC Adv. 2018 Aug 13;8(50):28700-28709. doi: 10.1039/c8ra05689g. eCollection 2018 Aug 7.
8
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.N-乙酰-L-半胱氨酸(NAC)在治疗精神障碍中的潜力。
CNS Drugs. 2022 May;36(5):451-482. doi: 10.1007/s40263-022-00907-3. Epub 2022 Mar 22.
9
MPTP-induced mouse model of Parkinson's disease: A promising direction of therapeutic strategies.MPTP 诱导的帕金森病小鼠模型:治疗策略的有前途方向。
Bosn J Basic Med Sci. 2021 Aug 1;21(4):422-433. doi: 10.17305/bjbms.2020.5181.
10
Modeling Parkinson's Disease With the Alpha-Synuclein Protein.用α-突触核蛋白模拟帕金森病
Front Pharmacol. 2020 Apr 23;11:356. doi: 10.3389/fphar.2020.00356. eCollection 2020.